In summary, our data demonstrate that a considerable proportion of Chinese cervical cancer patients harbor mutant PIK3CA. Patients with mutant PIK3CA tumors show significant differences when compared with patients with PIK3CA wild-type tumors with respect to age, menopausal status, histological subtype, treatment outcome and recurrent pattern after surgery-based multimodal therapy. Here, PIK3CA is linked to cervical carcinoma.